Quadrivio Group takes majority stake in Biotec Italia

Quadrivio Group has acquired a majority stake in Biotec Italia; an Italian developer, manufacturer and retailer of technological devices for the aesthetic medicine sector. 

It marks the fifth investment from Quadrivio’s Silver Economy Fund, which invests in European and US companies of ‘The Silver Age’. Namely, businesses that target clients in the ‘Baby Boomer’ and over-70s market segment, offering products and services to improve quality of life and complement aging. 

Founded in 1993, Biotec Italia offers solutions for non-invasive treatments to enhance the face and body. These include: diode lasers, intense pulsed lights, vacuum therapy, radiofrequency treatment, microdermabrasion, cryolipolysis and transdermal flux treatment. 

The investment joins a portfolio that includes CareHub, The Private Clinic of Harley Street, Siare Engineering International Group and Medical International Research.